Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
DUOXA2
REST API REST API
Homo sapiens
DUOXA2 is differentially expressed in 88 experiments: 41 organism parts: kidney medulla, mammary gland, ... (39 more);, 33 disease states: normal, glioblastoma, ... (31 more);, 28 cell types 58 cell lines 8 compound treatments and 43 other conditions.
Orthologs Duoxa2 (Mus musculus)   DUOXA2 (Danio rerio)   ENSGALG00000002454 (Gallus gallus)   ENSGALG00000002449 (Gallus gallus)   Duoxa2 (Rattus norvegicus)   ENSCING00000016175 (Ciona intestinalis)   ENSCING00000016143 (Ciona intestinalis)   ENSCING00000013783 (Ciona intestinalis)   DUOXA2 (Bos taurus)   mol (Drosophila melanogaster)   ENSXETG00000033172 (Xenopus laevis)   DOXA1_XENTR (Xenopus laevis)   DUOXA2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term endoplasmic reticulum, membrane, integral to membrane, endoplasmic reticulum membrane, protein transport
InterPro Term Dual_oxidase_maturation_fac
UniProt Accession Q1HG44
Gene-Disease Assocation THYROID DYSHORMONOGENESIS 5; TDH5
Search EB-eye ENSG00000140274
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-GEOD-18105, E-MTAB-69, E-AFMX-6, E-TABM-130, ... (9 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-MTAB-37, E-GEOD-19639, E-GEOD-6013, E-GEOD-24147, E-GEOD-19480, ... (8 experiments)

Factor Value U/D Experiments
SW620
1
E-MTAB-37
P3HR1
1
E-MTAB-37
CORL88
1
E-MTAB-37
CA46
1
E-MTAB-37
BT474
1
E-MTAB-37
Raji
1
E-MTAB-37
52 more value(s).


Cell type

studied in E-GEOD-18811, E-GEOD-22373, E-GEOD-20033, E-TABM-130, E-GEOD-1460, ... (16 experiments)

Factor Value U/D Experiments
centroblast
1
E-TABM-702
human embryonic stem cell
1
E-GEOD-20033
stromal cell
1
E-GEOD-1460
SCC
1
E-GEOD-19188
neutrophil
1
E-GEOD-12662
secretory cell
1
E-GEOD-3998
22 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-15960, E-MEXP-1121, E-GEOD-23878, ... (19 experiments)

Factor Value U/D Experiments
glioblastoma
2
E-GEOD-4412, E-GEOD-4290
asymptomatic HIV-1 infection
1
E-GEOD-16363
Becker muscular dystrophy
1
E-GEOD-3307
esophageal carcinoma
1
E-MTAB-37
tumor
1
E-GEOD-19188
spastic paraplegia
1
E-GEOD-3307
27 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-6400, E-MEXP-2241, E-GEOD-7307, E-GEOD-20081 ... (5 experiments)

Factor Value U/D Experiments
none
1
E-GEOD-7307
bacterial endotoxin
1
1
E-GEOD-3284
ethanol
2
1
E-MEXP-2241
actinomycin D
1
E-GEOD-6400
no estradiol
1
E-GEOD-20081
not specified
1
E-GEOD-20081
2 more value(s).


Biosource provider

studied in E-MTAB-37

Factor Value U/D Experiments
ECACC
1
E-MTAB-37


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-4667

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023

Genotype
studied in E-TABM-763, E-GEOD-17476, E-MEXP-421, E-GEOD-17347

Histology
studied in E-GEOD-21653

Individual
studied in E-TABM-325, E-GEOD-3284, E-MEXP-1243, E-MEXP-2069, E-TABM-666, ... (11 experiments)

Infection
studied in E-GEOD-12254, E-MEXP-561, E-GEOD-17400

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-12662

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Organism
studied in E-TABM-84

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-19246

Rna integrity
studied in E-TABM-325

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

sbr grade
studied in E-GEOD-21653

Stimulation
studied in E-GEOD-20114

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22152, E-GEOD-19246, E-GEOD-13818

Tumor grading
studied in E-GEOD-4271

Processing time: 0.427 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM